(Q43637059)

25 November 2017

title

The double-blind, randomized, placebo-controlled trial: gold standard or golden calf? (English)

1 reference

25 November 2017

1 reference

placebo-controlled trial

1 reference

Kaptchuk TJ

1

1 reference

25 November 2017

publication date

1 June 2001

1 reference

Journal of Clinical Epidemiology

25 November 2017

published in

1 reference

25 November 2017

volume

54

1 reference

25 November 2017

issue

6

1 reference

25 November 2017

page(s)

541-549

1 reference

Allocation of subjects in medical experiments.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Intentional ignorance: a history of blind assessment and placebo controls in medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Non-Randomized Controls in Cancer Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Placebo effect in double-blind clinical trials: a review of interactions with medications

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Understanding controlled trials. Why are randomised controlled trials important?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Allocation of Patients to Treatment in Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

A method for the evaluation of the effects of drugs on cardiac pain in patients with angina of effort; a study of khellin (visammin)

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

HOW TO evaluate a new drug

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Clinical research in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Glutamic acid and human intelligence

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Indomethacin: a survey of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Powerful placebo: the dark side of the randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Randomized versus historical controls for clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

A comparison of randomized concurrent control groups with matched historical control groups: are historical controls valid?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

A review and meta-analysis of hormonal treatment of cryptorchidism.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Assessment of the efficacy and safety of antiarrhythmic therapy for chronic atrial fibrillation: observations on the role of trial design and implications of drug-related mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Worldwide Collaborative Observational Study and Meta-Analysis on Allogenic Leukocyte Immunotherapy for Recurrent Spontaneous Abortion1

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

A meta-analysis of the therapeutic role of oil soluble contrast media at hysterosalpingography: a surprising result?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

How study design affects outcomes in comparisons of therapy. I: Medical

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

How study design affects outcomes in comparisons of therapy. II: Surgical.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Impact of random assignment on study outcome: An empirical examination

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Randomized, controlled trials, observational studies, and the hierarchy of research designs

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

A comparison of observational studies and randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Randomized trials or observational tribulations?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Bias in treatment assignment in controlled clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Sensitivity and specificity of clinical trials. Randomized v historical controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Why we need observational studies to evaluate the effectiveness of health care

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

The Cochrane Lecture. The best and the enemy of the good: randomised controlled trials, uncertainty, and assessing the role of patient choice in medical decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Understanding controlled trials. What is a patient preference trial?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Patients' preferences and randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Nonspecific effects in longitudinal studies: impact on quality of life measures

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Effect of instructions and nicotine on smoking cessation, withdrawal symptoms and self-administration of nicotine gum

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Do double-blind studies with informed consent yield externally valid results? An empirical test.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

The Interaction of Drugs with Placebos in the Control of Pain and Anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

THE EFFECT OF EXPECTATION ON RESPONSE TO PHENMETRAZINE

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

DRUG-SET INTERACTION: PSYCHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF EPINEPHRINE UNDER DIFFERENTIAL EXPECTATIONS.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

DRUGS AND PLACEBOS: THE EFFECTS OF INSTRUCTIONS UPON PERFORMANCE AND MOOD UNDER AMPHETAMINE SULPHATE AND CHLORAL HYDRATE.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

The interaction of psychologic stimuli and pharmacologic agents on airway reactivity in asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Response expectancy as a determinant of experience and behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Effects of suggestion and conditioning on the action of chemical agents in human subjects; the pharmacology of placebos

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Symposium on clinical drug evaluation and human pharmacology. IV. Placebos: problems and pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

A Study of the Variations in the Response Regarding Duodenal Ulcer when Treated with Placebo by Different Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

General practice consultations: is there any point in being positive?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Low status control, high effort at work and ischemic heart disease: prospective evidence from blue-collar men.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Adherence to treatment and health outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Patient preferences and randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Mortality in non-consenters in a post-myocardial infarction trial

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Applying results of randomised trials to clinical practice: impact of losses before randomisation.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Assessing non-consent bias with parallel randomized and nonrandomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Randomised controlled trials in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

The apparent incompatibility between informed consent and placebo-controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Meta-analysis: statistical alchemy for the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

Double-blind versus deceptive administration of a placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

The therapist-as-fixed-effect fallacy in psychotherapy research

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2800%2900347-4

7 January 2021

10.1016/S0895-4356(00)00347-4

Identifiers

DOI

1 reference

25 November 2017

1 reference